Our UK-made entry-level testers are built for tablets, capsules, powders and more. Simple, robust and trusted worldwide for reliable results every time. Learn more: copleyscientific.com/pharmaceutical…

Robust inhaler design starts with understanding how devices perform under real-world conditions. The Patient Exhalation Simulator, Drop Test Apparatus and NGI Tilting Platform help to assess the impact of patient technique and misuse on OINDP devices. bit.ly/device-robustn…

DecaVertus® III automates shaking and firing-to-waste of up to 10 MDIs at a timeMDI firing-to-waste, boosting throughput & reducing analyst fatigue. Save time, enhance reproducibility, and streamline your workflow. 🔗 copleyscientific.com/inhaler-testin…

📍 MVIC 2025, Lund (8-9 Oct): Visit our Silver Sponsor stand to see our latest OINDP innovations. 📍 Inhalation & Respiratory Conf, Barcelona (9-10 Oct): We’ll present on realistic in vitro testing approaches for bioequivalence. Our events: bit.ly/3KthnsU

We had a productive week at our HQ in Nottingham last week, training service engineers on our Vertus® III Automated Shake and Fire Systems. Hands-on sessions with our specialists ensure the best support and performance for every installation.

📚 Read how the trusted BEP2 Powder Flowability Tester was re-engineered to meet today’s market needs for powder testing - in our blog published today. copleyscientific.com/blogs/engineer… #PowderTesting #PowderFlowability #Pharmaceuticals #BulkProcessing

We’re thrilled to be named Small Business of the Year at the East Midlands Business Awards! Huge thanks to TheBusinessDesk and the judges. This win celebrates our team’s innovation in world-leading pharma testing equipment. Proud to represent the #EastMidlands!

Spend less time on data entry and more on insights! Inhalytix®+ connects directly with Copley equipment to centralise APSD data. Enjoy faster workflows, fewer errors, consistent results, and full traceability. Transform your APSD process today: Inhalytix.plus

Great to attend the IDDA Conference in Nanjing, China, and connect with experts from across the country. Dr Anny Shen presented on In Vivo–In Vitro Correlation Studies of Inhalation Products. Thanks to everyone we spoke with for the engaging discussions. #IDDAConference

One system. Every test. Vertus® III handles APS/D, DDU, spray force, plume temp & more for MDIs, nasal sprays & aerosols. Compatible with 40+ collection devices, it automates multiple workflows for better, more consistent data 🔗 bit.ly/vertus-iii

📚 Our blog today examines how real-world patient behaviour - from technique to device handling - can influence OINDP performance, and how it can be better accounted for when developing clinically reliable inhaled and nasal products. Read the full post at bit.ly/patient-behavi…

Why is dissolution testing rising in importance for orally inhaled products? Our CEO, Jamie Clayton breaks it down in our latest Expert View for ONdrugDelivery. 🔗copleyscientific.com/downloads/odd-… #Pharma #DrugDevelopment #InhalationScience #DissolutionTesting #OrallyInhaledProducts

Looking to improve APSD workflow efficiency? Watch our new inhalytix+ animation to see how one connected platform streamlines methods, results, equipment data, and audit trails. Learn more on our website: inhalytix.plus

A new standard is arriving in APSD drug recovery control and repeatability. Discover it first at DDL. #InhalerTesting #OINDPs #Pharmaceutical #Pharma #DDLConference #Innovation #CopleyScientific

Every tablet counts in QC. The FRVi Friability Tester series lets analysts quickly check how uncoated tablets withstand processing, handling, and transport. Friability and abrasion testing provide early insight into mechanical stability. Find out more: bit.ly/FRVi-Series

You’re closer than ever to a new standard in drug recovery precision. Get a first look at DDL this week - don’t miss it! #InhalerTesting #OINDPs #Pharmaceutical #Pharma #DDLConference #Innovation #CopleyScientific

Get the highlights from DDL 2025 in our new blog: key scientific themes, emerging trends, and practical insights from the inhaled drug delivery community. From dissolution testing to inhaled biologics and low-GWP propellants: copleyscientific.com/blogs/ddl-2025/

Happy New Year from Copley! 🎉 2026 marks 80 years of helping scientists improve people's lives. We thank you for being part of our story - the best is yet to come. #CopleyScientific #HelpingScientists